Balyasny Asset Management
BNTX icon

Balyasny Asset Management’s BioNTech BNTX Stock Holding History

Balyasny Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.1M Buy
463,163
+369,708
+396% +$34.8M 0.05% 412
2026
Q1 		$8.31M Buy
93,455
+90,043
+2,639% +$9.25M 0.01% 1118
2025
Q4 		$325K Buy
+3,412
New +$344K ﹤0.01% 2699
2025
Q2 		– Sell
-37,756
Closed -$3.44M – 2848
2025
Q1 		$3.44M Buy
+37,756
New +$4.23M 0.01% 1433
2024
Q4 		– Sell
-620,466
Closed -$73.7M – 2758
2024
Q3 		$73.7M Buy
620,466
+164,548
+36% +$15.1M 0.12% 187
2024
Q2 		$36.6M Buy
455,918
+265,816
+140% +$24.3M 0.06% 385
2024
Q1 		$17.5M Buy
+190,102
New +$18.2M 0.03% 674
2023
Q4 		– Sell
-348,728
Closed -$37.9M – 2509
2023
Q3 		$37.9M Buy
348,728
+195,104
+127% +$21.6M 0.08% 353
2023
Q2 		$16.6M Buy
+153,624
New +$17.3M 0.04% 593
2023
Q1 		– Sell
-113,528
Closed -$17.1M – 2671
2022
Q4 		$17.1M Buy
113,528
+105,691
+1,349% +$16.3M 0.05% 545
2022
Q3 		$1.06M Buy
7,837
+2,864
+58% +$438K ﹤0.01% 1771
2022
Q2 		$741K Sell
4,973
-103,495
-95% -$15.8M ﹤0.01% 1864
2022
Q1 		$18.5M Buy
+108,468
New +$18.2M 0.06% 444
2021
Q4 		– Sell
-38,455
Closed -$10.5M – 2253
2021
Q3 		$10.5M Buy
+38,455
New +$12.2M 0.04% 555
2020
Q4 		– Sell
-181,619
Closed -$17.8M – 1343
2020
Q3 		$12.6M Sell
181,619
-34,166
-16% -$2.45M 0.09% 323
2020
Q2 		$14.4M Buy
+215,785
New +$10.8M 0.12% 248

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Balyasny Asset Management's BNTX Position: Q2 2026 in Review

Balyasny Asset Management increased its BioNTech (BNTX) stake by 396% in Q2 2026, buying an estimated $34.8M and bringing the position to 463,163 shares worth $43.1M. The position accounts for 0.05% of the portfolio, ranked #412.

Balyasny Asset Management first reported a position in BNTX in Q2 2020 and has held it in 16 quarters since. The position peaked at $73.7M in Q3 2024. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Balyasny Asset Management held 463,163 shares of BioNTech worth $43.1M as of Q2 2026.
  • Balyasny Asset Management bought 369,708 BioNTech shares in Q2 2026, an estimated $34.8M.
  • BioNTech made up 0.05% of Balyasny Asset Management's portfolio in Q2 2026, its #412 holding.
  • Balyasny Asset Management first reported a position in BioNTech in Q2 2020 and has held it in 16 quarters since.
  • Balyasny Asset Management's BioNTech position peaked at $73.7M in Q3 2024.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.